{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ailanthone", "BER", "Gastric cancer", "Organoids", "P23"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34345209", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.7150/ijbs.60674"], "Journal": {"ISSN": "1449-2288", "JournalIssue": {"Volume": "17", "Issue": "11", "PubDate": {"Year": "2021"}}, "Title": "International journal of biological sciences", "ISOAbbreviation": "Int J Biol Sci"}, "ArticleTitle": "Ailanthus Altissima-derived Ailanthone enhances Gastric Cancer Cell Apoptosis by Inducing the Repression of Base Excision Repair by Downregulating p23 Expression.", "Pagination": {"StartPage": "2811", "EndPage": "2825", "MedlinePgn": "2811-2825"}, "Abstract": {"AbstractText": ["Chemotherapy plays an irreplaceable role in the treatment of GC, but currently available chemotherapeutic drugs are not ideal. The application of medicinal plants is an important direction for new drug discovery. Through drug screening of GC organoids, we determined that ailanthone has an anticancer effect on GC cells <i>in vitro</i> and <i>in vivo</i>. We also found that AIL can induce DNA damage and apoptosis in GC cells. Further transcriptome sequencing of PDX tissue indicated that AIL inhibited the expression of XRCC1, which plays an important role in DNA damage repair, and the results were also confirmed by western blotting. In addition, we found that AIL inhibited the expression of P23 and that inhibition of P23 decreased the expression of XRCC1, indicating that AIL can regulate XRCC1 via P23. The results of coimmunoprecipitation showed that AIL can inhibit the binding of P23 and XRCC1 to HSP90. These findings indicate that AIL can induce DNA damage and apoptosis in GC cells. Meanwhile, AIL can decrease XRCC1 activity by downregulating P23 expression to inhibit DNA damage repair. The present study sheds light on the potential application of new drugs isolated from natural medicinal plants for GC therapy."], "CopyrightInformation": "\u00a9 The author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Intervention, The People's Hospital of Guangxi Zhuang Autonomous Region,Nanning Guangxi 530021,P.R. China."}], "LastName": "Wang", "ForeName": "Chun-Ming", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Adult Stem Cell Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK."}, {"Identifier": [], "Affiliation": "The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK."}], "LastName": "Li", "ForeName": "Hua-Fu", "Initials": "HF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}], "LastName": "Wang", "ForeName": "Xiao-Kun", "Initials": "XK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Animal Experiment Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, P.R. China."}], "LastName": "Li", "ForeName": "Wu-Guo", "Initials": "WG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Animal Experiment Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, P.R. China."}], "LastName": "Su", "ForeName": "Qiao", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific research center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R.China."}], "LastName": "Xiao", "ForeName": "Xing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}], "LastName": "Hao", "ForeName": "Teng-Fei", "Initials": "TF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific research center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R.China."}], "LastName": "Chen", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}], "LastName": "Zhang", "ForeName": "Ya-Wei", "Initials": "YW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}], "LastName": "Zhang", "ForeName": "Hai-Yong", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}], "LastName": "Wu", "ForeName": "Wang", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific research center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R.China."}], "LastName": "Hu", "ForeName": "Zhen-Ran", "Initials": "ZR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Animal Experiment Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, P.R. China."}], "LastName": "Zhao", "ForeName": "Guang-Yin", "Initials": "GY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}], "LastName": "Huo", "ForeName": "Ming-Yu", "Initials": "MY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Gastrointestinopancreatic Surgery, The First Affiliated Hospital of Sun Yat\u2011Sen University, Guangzhou, Guangdong 510080, P.R. China."}], "LastName": "He", "ForeName": "Yu-Long", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Digestive Disease Center, The Seventh Affiliated Hospital of Sun Yat\u2011Sen University, Shenzhen, Guangdong 518107, P.R. China."}], "LastName": "Zhang", "ForeName": "Chang-Hua", "Initials": "CH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Int J Biol Sci", "NlmUniqueID": "101235568", "ISSNLinking": "1449-2288"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Quassins"}, {"RegistryNumber": "0", "NameOfSubstance": "X-ray Repair Cross Complementing Protein 1"}, {"RegistryNumber": "0", "NameOfSubstance": "XRCC1 protein, human"}, {"RegistryNumber": "81R511UV73", "NameOfSubstance": "Pyridinolcarbamate"}, {"RegistryNumber": "981-15-7", "NameOfSubstance": "ailanthone"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Ailanthus"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Damage"}, {"QualifierName": ["drug effects"], "DescriptorName": "DNA Repair"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["metabolism"], "DescriptorName": "Pyridinolcarbamate"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quassins"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Stomach Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "X-ray Repair Cross Complementing Protein 1"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}], "CoiStatement": "Competing Interests: The authors have declared that no competing interest exists."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray F, Ferlay J, Soerjomataram I, Siegel R L, Torre L A, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J] Ca-A Cancer Journal for Clinicians. 2018;68(6):394\u2013424.", "ArticleIdList": ["30207593"]}, {"Citation": "Al-Batran S E, Homann N, Pauligk C, Goetze T O, Meiler J, Kasper S. et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial[J] Lancet. 2019;393(10184):1948\u20131957.", "ArticleIdList": ["30982686"]}, {"Citation": "Holohan C, Van Schaeybroeck S, Longley D B, Johnston P G. Cancer drug resistance: an evolving paradigm[J] Nat Rev Cancer. 2013;13(10):714\u2013726.", "ArticleIdList": ["24060863"]}, {"Citation": "Lumlerdkij N, Tantiwongse J, Booranasubkajorn S, Boonrak R, Akarasereenont P, Laohapand T. et al. Understanding cancer and its treatment in Thai traditional medicine: An ethnopharmacological-anthropological investigation[J] J Ethnopharmacol. 2018;216:259\u2013273.", "ArticleIdList": ["29409982"]}, {"Citation": "Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z. et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer[J] Biosci Trends. 2015;9(1):16\u201334.", "ArticleIdList": ["25787906"]}, {"Citation": "Wang P, Yang H L, Yang Y J, Wang L, Lee S C. Overcome Cancer Cell Drug Resistance Using Natural Products[J] Evid Based Complement Alternat Med. 2015;2015:767136.", "ArticleIdList": ["PMC4569777", "26421052"]}, {"Citation": "Da R A, Lopes R M, Schwartsmann G. Natural products in anticancer therapy[J] Curr Opin Pharmacol. 2001;1(4):364\u2013369.", "ArticleIdList": ["11710734"]}, {"Citation": "Cucci M A, Grattarola M, Dianzani C, Damia G, Ricci F, Roetto A. et al. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism[J] Free Radical Biology and Medicine. 2020;150:125\u2013135.", "ArticleIdList": ["32101771"]}, {"Citation": "Hou S, Cheng Z, Wang W, Wang X, Wu Y. Ailanthone exerts an antitumor function on the development of human lung cancer by upregulating microRNA-195[J] J Cell Biochem. 2019;120(6):10444\u201310451.", "ArticleIdList": ["30565729"]}, {"Citation": "Gao W, Ge S, Sun J. Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion[J] Biomed Pharmacother. 2019;109:1062\u20131069.", "ArticleIdList": ["30551356"]}, {"Citation": "Daga M, Pizzimenti S, Dianzani C, Cucci M A, Cavalli R, Grattarola M. et al. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.[J] Phytomedicine. 2019;56:156\u2013164.", "ArticleIdList": ["30668336"]}, {"Citation": "Wei C, Chen C, Cheng Y, Zhu L, Wang Y, Luo C. et al. Ailanthone induces autophagic and apoptotic cell death in human promyelocytic leukemia HL-60 cells[J] Oncol Lett. 2018;16(3):3569\u20133576.", "ArticleIdList": ["PMC6096173", "30127963"]}, {"Citation": "Wang R, Lu Y, Li H, Sun L, Yang N, Zhao M. et al. Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF-7 cells[J] Oncol Lett. 2018;15(4):6022\u20136028.", "ArticleIdList": ["PMC5840722", "29552229"]}, {"Citation": "Yang P, Sun D, Jiang F. Ailanthone Promotes Human Vestibular Schwannoma Cell Apoptosis and Autophagy by Downregulation of miR-21[J] Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2018;26(6):941\u2013948.", "ArticleIdList": ["PMC7844645", "29298734"]}, {"Citation": "Chen Y, Zhu L, Yang X, Wei C, Chen C, He Y. et al. Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells[J] Molecular Medicine Reports. 2017;16(5):6821\u20136827.", "ArticleIdList": ["PMC5865840", "28901518"]}, {"Citation": "Ni Z, Yao C, Zhu X, Gong C, Xu Z, Wang L. et al. Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1[J] British Journal of Cancer. 2017;117(11):1621\u20131630.", "ArticleIdList": ["PMC5729430", "29024939"]}, {"Citation": "He Y, Peng S, Wang J, Chen H, Cong X, Chen A, Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer[Z] 2016; p: 7.", "ArticleIdList": ["PMC5159881", "27959342"]}, {"Citation": "Zhuo Z, Hu J, Yang X, Chen M, Lei X, Deng L, Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In vitro and In vivo[J] Scientific Reports. 2015. 5(1)", "ArticleIdList": ["PMC4630794", "26525771"]}, {"Citation": "Duncan E J, Cheetham M E, Chapple J P, van der Spuy J. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease[J] Subcell Biochem. 2015;78:243\u2013273.", "ArticleIdList": ["25487025"]}, {"Citation": "Seidlitz T, Merker S R, Rothe A, Zakrzewski F, von Neubeck C, Grutzmann K. et al. Human gastric cancer modelling using organoids[J] Gut. 2019;68(2):207\u2013217.", "ArticleIdList": ["PMC6352409", "29703791"]}, {"Citation": "Takaishi S, Okumura T, Tu S, Wang S S, Shibata W, Vigneshwaran R. et al. Identification of gastric cancer stem cells using the cell surface marker CD44[J] Stem Cells. 2009;27(5):1006\u20131020.", "ArticleIdList": ["PMC2746367", "19415765"]}, {"Citation": "Marangoni E, Laurent C, Coussy F, El-Botty R, Ch\u00e2teau-Joubert S, Servely J. et al. Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers[J] Clinical Cancer Research. 2018;24(11):2605\u20132615.", "ArticleIdList": ["29463559"]}, {"Citation": "Li B, Dewey C N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome[J] BMC Bioinformatics. 2011;12:323.", "ArticleIdList": ["PMC3163565", "21816040"]}, {"Citation": "Tu Y. Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture)[J] Angew Chem Int Ed Engl. 2016;55(35):10210\u201310226.", "ArticleIdList": ["27488942"]}, {"Citation": "Hui Z R G W. Pharmacopoeia of the People's Republic of China /[M] Chemical Industry Press. 2000."}, {"Citation": "Okunade A L, Bikoff R E, Casper S J, Oksman A, Goldberg D E, Lewis W H. Antiplasmodial activity of extracts and quassinoids isolated from seedlings of Ailanthus altissima (Simaroubaceae)[J] Phytother Res. 2003;17(6):675\u2013677.", "ArticleIdList": ["12820239"]}, {"Citation": "Caldecott K W. XRCC1 protein; Form and function[J] DNA Repair (Amst) 2019;81:102664.", "ArticleIdList": ["31324530"]}, {"Citation": "London R E. The structural basis of XRCC1-mediated DNA repair[J] DNA Repair. 2015;30:90\u2013103.", "ArticleIdList": ["PMC5580684", "25795425"]}, {"Citation": "Mourgues S, Lomax M E, O'Neill P. Base excision repair processing of abasic site/single-strand break lesions within clustered damage sites associated with XRCC1 deficiency[J] Nucleic Acids Res. 2007;35(22):7676\u20137687.", "ArticleIdList": ["PMC2190709", "17982170"]}, {"Citation": "Peng S, Yi Z, Liu M. Ailanthone: a new potential drug for castration-resistant prostate cancer[J] Chin J Cancer. 2017;36(1):25.", "ArticleIdList": ["PMC5336637", "28257652"]}, {"Citation": "Talaei S, Mellatyar H, Asadi A, Akbarzadeh A, Sheervalilou R, Zarghami N. Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment[J] Chem Biol Drug Des. 2019;93(5):760\u2013786.", "ArticleIdList": ["30697932"]}, {"Citation": "Echtenkamp F J, Zelin E, Oxelmark E, Woo J I, Andrews B J, Garabedian M. et al. Global functional map of the p23 molecular chaperone reveals an extensive cellular network[J] Mol Cell. 2011;43(2):229\u2013241.", "ArticleIdList": ["PMC3155841", "21777812"]}, {"Citation": "Dezwaan D C, Freeman B C. HSP90: the Rosetta stone for cellular protein dynamics?[J] Cell Cycle. 2008;7(8):1006\u20131012.", "ArticleIdList": ["18414022"]}, {"Citation": "Solier S, Kohn K W, Scroggins B, Xu W, Trepel J, Neckers L. et al. Heat shock protein 90alpha (HSP90alpha), a substrate and chaperone of DNA-PK necessary for the apoptotic response[J] Proc Natl Acad Sci U S a. 2012;109(32):12866\u201312872.", "ArticleIdList": ["PMC3420188", "22753480"]}, {"Citation": "Tung C L, Jian Y J, Syu J J, Wang T J, Chang P Y, Chen C Y. et al. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells[J] Exp Cell Res. 2015;334(1):126\u2013135.", "ArticleIdList": ["25662161"]}, {"Citation": "Shim H J, Yun J Y, Hwang J E, Bae W K, Cho S H, Lee J H. et al. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin[J] Cancer Sci. 2010;101(5):1247\u20131254.", "ArticleIdList": ["20331623"]}, {"Citation": "Caldecott K W. Single-strand break repair and genetic disease[J] Nat Rev Genet. 2008;9(8):619\u2013631.", "ArticleIdList": ["18626472"]}, {"Citation": "Chiosis G, Neckers L. Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive[J] ACS Chem Biol. 2006;1(5):279\u2013284.", "ArticleIdList": ["17163756"]}, {"Citation": "Johnson J L, Toft D O. A novel chaperone complex for steroid receptors involving heat shock proteins, immunophilins, and p23[J] J Biol Chem. 1994;269(40):24989\u201324993.", "ArticleIdList": ["7929183"]}, {"Citation": "Fang Q, Inanc B, Schamus S, Wang X H, Wei L, Brown A R. et al. HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase beta[J] Nat Commun. 2014;5:5513.", "ArticleIdList": ["PMC4246423", "25423885"]}, {"Citation": "Simpson N E, Lambert W M, Watkins R, Giashuddin S, Huang S J, Oxelmark E. et al. High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance[J] Cancer Research. 2010;70(21):8446\u20138456.", "ArticleIdList": ["PMC3007122", "20847343"]}, {"Citation": "Cano L Q, Lavery D N, Sin S, Spanjaard E, Brooke G N, Tilman J D. et al. The co-chaperone p23 promotes prostate cancer motility and metastasis[J] Mol Oncol. 2015;9(1):295\u2013308.", "ArticleIdList": ["PMC4510206", "25241147"]}, {"Citation": "Lau H, Kranenburg O, Xiao H, Yu J. Organoid models of gastrointestinal cancers in basic and translational research[J] Nat Rev Gastroenterol Hepatol. 2020.", "ArticleIdList": ["32099092"]}, {"Citation": "Ooft S N, Weeber F, Dijkstra K K, Mclean C M, Kaing S, van Werkhoven E, Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients[J] Sci Transl Med. 2019. 11(513)", "ArticleIdList": ["31597751"]}, {"Citation": "Steele N G, Chakrabarti J, Wang J, Biesiada J, Holokai L, Chang J. et al. An Organoid-Based Preclinical Model of Human Gastric Cancer[J] Cellular and Molecular Gastroenterology and Hepatology. 2019;7(1):161\u2013184.", "ArticleIdList": ["PMC6279812", "30522949"]}, {"Citation": "Fatehullah A, Tan S H, Barker N. Organoids as an in vitro model of human development and disease[J] Nat Cell Biol. 2016;18(3):246\u2013254.", "ArticleIdList": ["26911908"]}, {"Citation": "Pennisi R, Ascenzi P, di Masi A. Hsp90: A New Player in DNA Repair?[J] Biomolecules. 2015;5(4):2589\u20132618.", "ArticleIdList": ["PMC4693249", "26501335"]}, {"Citation": "Workman P. Altered states: selectively drugging the Hsp90 cancer chaperone[J] Trends Mol Med. 2004;10(2):47\u201351.", "ArticleIdList": ["15106614"]}, {"Citation": "Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa W C. et al. Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis[J] Oncogene. 2005;24(24):3954\u20133963.", "ArticleIdList": ["15782121"]}, {"Citation": "Pratt W B, Dittmar K D. Studies with Purified Chaperones Advance the Understanding of the Mechanism of Glucocorticoid Receptor-hsp90 Heterocomplex Assembly[J] Trends Endocrinol Metab. 1998;9(6):244\u2013252.", "ArticleIdList": ["18406276"]}, {"Citation": "Ali R, Al-Kawaz A, Toss M S, Green A R, Miligy I M, Mesquita K A. et al. Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma in situ Induces Synthetic Lethality and Chemoprevention[J] Cancer Research. 2018;78(24):6818\u20136827.", "ArticleIdList": ["30297533"]}, {"Citation": "Simpson N E, Lambert W M, Watkins R, Giashuddin S, Huang S J, Oxelmark E. et al. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance[J] Cancer Res. 2010;70(21):8446\u20138456.", "ArticleIdList": ["PMC3007122", "20847343"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "20"}, {"Year": "2021", "Month": "5", "Day": "21"}, {"Year": "2021", "Month": "8", "Day": "4", "Hour": "7", "Minute": "5"}, {"Year": "2021", "Month": "8", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["34345209", "PMC8326126", "10.7150/ijbs.60674", "ijbsv17p2811"]}}], "PubmedBookArticle": []}